IFU
UTHR icon

iSAM Funds (UK)’s United Therapeutics UTHR Stock Holding History

iSAM Funds (UK)’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,798
Closed -$517K – 827
2025
Q2 		$517K Buy
+1,798
New +$537K 0.11% 267
2024
Q1 		– Sell
-1,305
Closed -$287K – 351
2023
Q4 		$287K Buy
+1,305
New +$301K 0.2% 150
2023
Q3 		– Sell
-1,195
Closed -$264K – 336
2023
Q2 		$264K Buy
+1,195
New +$265K 0.24% 153

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

iSAM Funds (UK)'s UTHR Position: Q3 2025 in Review

iSAM Funds (UK) sold out of United Therapeutics (UTHR) in Q3 2025, closing a stake of 1,798 shares — an estimated $517K sold.

iSAM Funds (UK) first reported a position in UTHR in Q2 2023 and held it in 3 quarters. The position peaked at $517K in Q2 2025. 708 funds tracked by Wall St. Rank hold UTHR as of Q3 2025.

  • iSAM Funds (UK) reported no remaining United Therapeutics position as of Q3 2025 after selling out during the quarter.
  • iSAM Funds (UK) sold 1,798 United Therapeutics shares in Q3 2025, an estimated $517K.
  • iSAM Funds (UK) first reported a position in United Therapeutics in Q2 2023 and held it in 3 quarters.
  • iSAM Funds (UK)'s United Therapeutics position peaked at $517K in Q2 2025.
  • 708 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2025.

Based on iSAM Funds (UK)'s 13F filing for Q3 2025, filed 14 Nov 2025.